Patienter, der rapporterer om rygetrang, rygeophør og forstærkende virkning af rygning I den aktive behandlingsperiode i både forsøg 1 og 2 var rygetrang og rygeophør signifikant nedsat hos patienter randomiseret til CHAMPIX sammenlignet med placebo.
Patient reported craving, withdrawal and reinforcing effects of smoking Across both Studies 1 and 2 during active treatment, craving and withdrawal were significantly reduced in patients randomized to CHAMPIX in comparison with placebo.